Squarepoint’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $483K | Sell |
14,862
-330,020
| -96% | -$10.7M | ﹤0.01% | 1935 |
|
|
2025
Q1 | $13M | Sell |
344,882
-31,964
| -8% | -$1.21M | 0.02% | 476 |
|
|
2024
Q4 | $30.8M | Buy |
376,846
+313,354
| +494% | +$25.7M | 0.03% | 254 |
|
|
2024
Q3 | $7.26M | Buy |
63,492
+40,136
| +172% | +$4.59M | 0.01% | 597 |
|
|
2024
Q2 | $1.76M | Buy |
+23,356
| New | +$1.76M | ﹤0.01% | 1117 |
|
|
2023
Q3 | – | Sell |
-5,140
| Closed | -$257K | – | 2747 |
|
|
2023
Q2 | $257K | Sell |
5,140
-20,029
| -80% | -$1M | ﹤0.01% | 1945 |
|
|
2023
Q1 | $943K | Sell |
25,169
-3,874
| -13% | -$145K | ﹤0.01% | 1195 |
|
|
2022
Q4 | $1.39M | Buy |
29,043
+20,000
| +221% | +$959K | 0.01% | 938 |
|
|
2022
Q3 | $217K | Buy |
+9,043
| New | +$217K | ﹤0.01% | 1760 |
|
|
2021
Q3 | – | Sell |
-16,504
| Closed | -$372K | – | 2622 |
|
|
2021
Q2 | $372K | Buy |
+16,504
| New | +$372K | ﹤0.01% | 1816 |
|
|
2021
Q1 | – | Sell |
-11,233
| Closed | -$298K | – | 2931 |
|
|
2020
Q4 | $298K | Buy |
+11,233
| New | +$298K | ﹤0.01% | 1860 |
|